Familial Hypercholesterolemia and Lipoprotein Apheresis

Lipoprotein apheresis has been developed as the treatment for refractory familial hypercholesterolemia (FH) to remove low-density lipoprotein (LDL), which is the main pathogenic factor. Currently, three procedures are available in Japan, including the plasma exchange, double-membrane filtration, and...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Atheroscler Thromb
Asıl Yazarlar: Makino, Hisashi, Koezuka, Ryo, Tamanaha, Tamiko, Ogura, Masatsune, Matsuki, Kota, Hosoda, Kiminori, Harada-Shiba, Mariko
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Japan Atherosclerosis Society 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6711846/
https://ncbi.nlm.nih.gov/pubmed/31231083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5551/jat.RV17033
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller